Catheter Precision (VTAK) announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in purchase orders each for LockeT by the end of 2025. These hospitals include Montefiore, Eisenhower Health, and Overland Park Regional Medical Center.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VTAK:
- Catheter Precision Stock (VTAK) Rockets 170% on a Delayed Investor Reaction
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories
- Catheter Precision secures VIVO purchase order
- Catheter Precision Approves Warrant Issuance to Ladenburg
- Catheter Precision Announces CCO Departure and Leadership Change